US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      FOREST RIVER ( 22V450000 )

      Dated: JUN 24, 2022 Forest River, Inc. (Forest River) is recalling certain 2022 RPOD RPT153 travel trailers. The Federal Placard states an incorrect … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Hospira Issues A Voluntary Nationwide Recall For Labetalol Hydrochloride Injection, USP, Due To The Potential Of Cracked Glass At The Rim Surface Of The Vials

Hospira Issues A Voluntary Nationwide Recall For Labetalol Hydrochloride Injection, USP, Due To The Potential Of Cracked Glass At The Rim Surface Of The Vials

February 23, 2018 By The FDA Leave a Comment

Hospira, Inc., a Pfizer company, is voluntarily recalling 3 lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial (NDC 0409-2267-20), and one lot of Labetalol Hydrochloride Injection, USP, Novaplus® (NDC 0409-2267-25) to the hospital/institution level. Hospira, Inc. initiated this recall due to the discovery of cracks on the rim surface of vials for these lots, which is covered by the stopper and crimp seal.

Cracked vials may result in a lack of sterility assurance for the product. Use of or exposure to a non-sterile product may be associated with adverse events such as fever, chills, sepsis or invasive systemic infections in patients. To date, Hospira, Inc. has not received any reports of adverse events associated with this issue for these lots.

Labetalol Hydrochloride is an adrenergic receptor blocking agent indicated for the control of blood pressure (BP) in severe hypertension. It is administered by repeated intravenous (IV) injections or by slow IV infusion.

Labetalol Hydrochloride Injection is packaged in a 20 mL Multiple Dose Fliptop Vial; packaged in 50 cartons per case. The affected lots include the following NDC, lot numbers, and expiry dates. For cartons, the NDC is located on the top and front label and Lot and Expiry Date information is located on the bottom.  For individual vials, the NDC, Lot and Expiry Date information is located on the vial label.

Product was distributed nationwide to wholesalers / retailers / hospitals in the United States and Puerto Rico from April 2017 to August 2017.

NDC Lot Number Expiration Date Strength Configuration/Count

0409-2267-20

74370DD
75035DD
75115DD

1FEB2019
1MAR2019
1MAR2019

100 mg/20 mL
(5 mg/mL)

1-20 mL Multiple Dose Fliptop Vial per carton; 50 cartons per case

0409-2267-25 (Novaplus®)

74230DD

1FEB2019

100 mg/20 mL
(5 mg/mL)

1-20 mL Multiple Dose Fliptop Vial per carton; 50 cartons per case

Hospira, Inc. places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process.

Hospira, Inc. has notified wholesalers/retailers/hospitals by recall letter to arrange for return of any recalled product.

Wholesalers/retailers/hospitals/institutions with an existing inventory of the lots subject to this recall should stop use and distribution of the remaining units and quarantine immediately. Healthcare Professionals in your organization should be informed of this recall. If you have further distributed the recalled product, to the wholesale or retail level, please notify any accounts or additional locations which may have received the recalled product from you. For additional assistance, call Stericycle at 1-800-805-3093 between the hours of 8 a.m. to 5 p.m. ET, Monday through Friday.

Retailers/ Healthcare Professionals with questions regarding this recall can contact Pfizer using the below information.

Contact Contact Information Areas of Support

Pfizer Medical

Information

1- 800-615-0187 , option 3

(8am to 7pm ET Monday through Friday)

Medical inquiries

Pfizer Safety

1-800-438-1985, option 1 (24 hours a day 7 days per week)

To report adverse events or product complaints

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being executed with the knowledge of the U.S. Food and Drug Administration.

###

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

FOREST RIVER ( 22V450000 )

June 30, 2022 By NHTSA

ISUZU ( 22V434000 )

June 30, 2022 By NHTSA

AUTOCAR ( 22V437000 )

June 30, 2022 By NHTSA

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

A&M Farms Initiates a Recall Of Specific Little Bear Brand Whole Vidalia Onions Sold By The Pound at Retail Because of Possible Health Risk

June 29, 2022 By The FDA

TOYOTA ( 22V445000 )

June 29, 2022 By NHTSA

FREIGHTLINER ( 22V443000 )

June 29, 2022 By NHTSA

GRAND DESIGN ( 22V442000 )

June 29, 2022 By NHTSA

GMC ( 22V446000 )

June 29, 2022 By NHTSA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

GRAND DESIGN ( 22V442000 )

June 29, 2022 By NHTSA

GMC ( 22V446000 )

June 29, 2022 By NHTSA

KIA ( 22V447000 )

June 29, 2022 By NHTSA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • FOREST RIVER ( 22V450000 )
  • ISUZU ( 22V434000 )
  • AUTOCAR ( 22V437000 )
  • FORD ( 22V451000 )
  • NISSAN ( 22V457000 )
  • A&M Farms Initiates a Recall Of Specific Little Bear Brand Whole Vidalia Onions Sold By The Pound at Retail Because of Possible Health Risk
  • TOYOTA ( 22V445000 )
  • FREIGHTLINER ( 22V443000 )
  • GRAND DESIGN ( 22V442000 )
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2022 Altrumedia · Terms of Service · Log in